Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.57 USD
Change Today +0.06 / 3.97%
Volume 1.8M
CTIC On Other Exchanges
As of 8:10 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Louis A. Bianco CPA

Co-Founder, Principal Financial Officer, Principal Accounting Officer, Chief Governance Officer, Executive Vice President of Finance & Administration and Secretary,CTI BioPharma Corp.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Mr. Louis A. Bianco, CPA is a Co- Founder of CTI BioPharma Corp. and has been its Executive Vice President of Finance and Administration since February 1, 1992. Mr. Bianco serves as Principal Accounting Officer, Principal Financial Officer and Secretary of CTI BioPharma Corp. and has been its Chief Governance Officersince September 2013. From January 1989 to January 1992, he served as a Vice President at Deutsche Bank Capital Corporation in charge of risk management. ...

Read Full Background

Corporate Headquarters*

3101 Western Avenue
Seattle, Washington 98121

United States

Phone: 206-282-7100
Fax: 206-284-6206

Board Members Memberships*

There is no Board Members Memberships data available.


New York University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$594,000

Stock Options*

Restricted Stock Awards$1,542,615
All Other Compensation$42,299
Exercisable Options200,428
Exercisable Options Value$118,000
Total Value of Options$118,000
Total Number of Options200,428

Total Compensation*

Total Annual Cash Compensation$636,299
Total Short Term Compensation$594,000
Other Long Term Compensation$1,584,914
Total Calculated Compensation$2,178,914
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CTIC:US $1.57 USD +0.06


Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
Raul R. Rodriguez Chief Executive Officer, President, Director and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
Ricardo J. Gonzalez Chief Executive Officer, President and Director
Navidea Biopharmaceuticals, Inc
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CTI BIOPHARMA CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at